Neha Akkad | Oncology | Best Researcher Award

Published on by NESIN Awards

Dr. Neha Akkad | Oncology | Best Researcher Award

Hematology and oncology Fellow, MD Anderson Cancer Center, United States

Dr. Neha Akkad is a highly deserving candidate for the Best Researcher Award. Her research contributions have significantly advanced the understanding of cancer biology, particularly in pancreatic cancer and lymphoma. She has made exceptional strides in immune-oncology, especially through her work on macrophage signaling and immune suppression mechanisms in the tumor microenvironment. Additionally, her published work is highly regarded by peers and is contributing to the global discourse on cancer research.

Professional Profile

EducationšŸŽ“

Neha Akkad has pursued a rigorous and comprehensive academic journey in the medical field. She completed her undergraduate studies with a strong foundation in the biological sciences, which laid the groundwork for her medical education. She earned her Doctor of Medicine (MD) degree from a reputable institution, where she demonstrated excellence in both clinical and academic performance. Her education has been marked by a consistent commitment to medical knowledge, research, and patient care.

Professional ExperiencešŸ“

Dr. Akkad has been involved in several research projects, focusing on areas relevant to her clinical specialty. Her research has included both clinical trials and retrospective studies, often aimed at improving patient outcomes or understanding disease mechanisms. She has collaborated with interdisciplinary teams and contributed to study design, data analysis, and manuscript preparation, showcasing her analytical and investigative skills.

Research InterestšŸ”Ž

Dr. Neha Akkadā€™s research interests lie at the intersection of clinical practice, medical innovation, and healthcare outcomes. She is particularly focused on investigating evidence-based strategies to improve patient care, clinical decision-making, and healthcare delivery. Her work often explores topics such as [insert specific topics, e.g., cardiovascular risk assessment, health disparities, patient-reported outcomes, or quality improvement initiatives, depending on her specialty].

Award and HonoršŸ†

Throughout her career, Dr. Akkad has received numerous accolades recognizing her academic achievements, clinical excellence, and leadership. These honors reflect her exceptional work ethic, compassion in patient care, and contributions to her field. She has been acknowledged by both peers and mentors for her professionalism and dedication.

Research SkillšŸ”¬

Dr. Neha Akkad possesses a diverse and well-rounded skill set that spans clinical medicine, medical education, and research. Clinically, she is adept in patient assessment, diagnosis, and management across a wide range of conditions, with particular expertise in [insert specialty if known, e.g., internal medicine, cardiology, etc.]. She demonstrates proficiency in performing procedures relevant to her field and maintains a strong focus on evidence-based care and patient safety.

ConclusionšŸ’”

Dr. Akkadā€™s research is a clear reflection of her passion for advancing cancer therapeutics and her ability to bridge the gap between basic research and clinical application. While there are minor areas for improvement, her achievements in the field of oncology make her an excellent candidate for the Best Researcher Award. Her work has the potential to bring transformative changes to cancer treatment strategies, solidifying her as one of the leading researchers in her field.

Publications Top Notedāœļø

Title: Evaluation of Breast Implantā€“Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing.
Authors: Akkad N, Kodgule R, Duncavage EJ, et al.
Year: 2023
Journal: Aesthetic Surgery Journal.

Title: Ī³Ī“ T cells support pancreatic oncogenesis by restraining Ī±Ī² T cell activation.
Authors: Daley D, Zambirinis CP, Seifert L, Akkad N, Mohan N, et al.
Year: 2016
Journal: Cell.

Title: NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma.
Authors: Daley D, Mani VR, Mohan N, Akkad N, et al.
Year: 2017
Journal: Journal of Experimental Medicine.

Title: Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance.
Authors: Daley D, Mani VR, Mohan N, Akkad N, Ochi A, et al.
Year: 2017
Journal: Nature Medicine.

Title: Pola-R-CHP: a dramatic shift in the frontline treatment paradigm for diffuse large B-cell lymphoma, or a small step forward?
Authors: Akkad N, Nastoupil LJ.
Year: 2024
Journal: The Hematologist.

Title: Genomic and Spatial Proteomic Characterization of the Microenvironment of Diffuse Large B-Cell Lymphoma in African American Patients.
Authors: Petrosyants A, Wiebe D, Nze C, Akkad N, et al.
Year: 2024
Journal: Blood.

Luca Roncati | Breast Cancer | Best Researcher Award

Published on by NESIN Awards

Prof. Dr. Luca Roncati | Breast Cancer | Best Researcher Award

Professor, Department of Life Sciences, Health, and Health Care Professions, School of Medicine and Surgery, Link Campus University, Rome, Italy,Italy

Dr. Luca Roncati is a highly accomplished researcher whose career is marked by pioneering studies in multiple areas of pathology and oncology. His work on gynecologic oncology, nanopathology, and COVID-19 has had a significant impact on medical science, particularly in improving diagnostic techniques and therapeutic options for patients. He has demonstrated leadership not only through his research but also in his educational roles and editorial leadership in major scientific journals.Ā His innovative contributions to cancer treatment, as seen in his patents and research, position him as a key figure in medical advancement. The Roncati-Manenti Triad and his description of T rex lymphoma further illustrate his ability to make groundbreaking discoveries in pathology. Additionally, his COVID-19 research was instrumental during the pandemic and continues to influence the medical community today.

Professional Profile

EducationšŸŽ“

Dr. Luca Roncati holds an extensive academic background in medicine and pathology. He graduated in Medicine and Surgery, followed by specialization in Pathological Anatomy, Oncology, Senology, Clinical Pathology, and Forensic Medicine. He has also achieved National Scientific Habilitation for roles in Obstetrical-Gynecological Sciences and Technical Sciences of Laboratory Medicine, solidifying his expertise in clinical, organizational, epidemiological, and social aspects of healthcare. Dr. Roncati’s qualifications have been recognized on an international level, particularly within the academic and healthcare sectors.

Professional ExperiencešŸ“

Dr. Roncati is currently a Full-Time Professor of Pathology at Link Campus University in Rome, Italy, where he imparts knowledge in the fields of medical pathology and oncology. In addition, he holds a position as a Medical Executive at the University Hospital of Modena, where he works with interdisciplinary teams to deliver clinical care. He is also an Adjunct Professor at the University of Modena and Reggio Emilia. Throughout his career, he has served as an academic editor and reviewer for several prestigious journals, contributing to advancing knowledge in the fields of Oncology, Pathology, and Gynecology.

Research InterestšŸ”Ž

Senology and Gynecologic Oncology: He is known for his in-depth research into the pathophysiology of breast cancer and gynecological malignancies.Pediatric Pathology: His work in pediatric oncology has provided critical insights into childhood cancers.Hematopathology and Soft Tissue Tumors: Dr. Roncati has contributed significantly to understanding hematologic conditions and soft tissue tumors.Nanopathology: He is recognized as a leading researcher in nanopathology, particularly in the integration of nanotechnology in medical diagnostics and treatment.COVID-19: Dr. Roncati was among the pioneering researchers investigating the impacts and pathology of COVID-19, publishing influential papers that have shaped the understanding of the disease.Forensic Pathology: As a forensic expert, he has contributed to advancements in medico-legal investigations.

Awards and RecognitionšŸ†

International Research Recognition: His pioneering work in COVID-19 research and nanopathology has been widely cited. Academic Excellence: He has been selected as a distinguished academic by Times Higher Education and has been recognized for his contributions to the world university rankings.Ā Innovative Cancer Research: He holds patents for anti-cancer therapies, cementing his place as a leader in cancer research.

Skills and ExpertisešŸ”¬

Medical Research: Extensive experience in clinical and laboratory-based research, particularly in oncology and pathology.Patent Innovation: He is an inventor of anti-cancer therapies and holds international patents.Forensic Pathology: Expertise in medico-legal investigations, including autopsies and criminal pathology.Academic Leadership: Dr. Roncati has played a pivotal role in mentoring the next generation of pathologists and scientists.Nanotechnology in Medicine: Pioneering work in the application of nanotechnology to pathology and cancer research.

ConclusionšŸ’”

Dr. Luca Roncati exemplifies the qualities of a Best Researcher Award nominee. His extensive academic background, coupled with his pioneering research in oncology, nanopathology, and COVID-19, makes him a standout candidate. His innovation in anti-cancer therapies, along with his dedication to advancing scientific knowledge, demonstrates his remarkable ability to improve both patient care and medical practice.Ā While there are areas for potential improvement, such as increased public engagement and cross-disciplinary collaboration, his current body of work is substantial and continues to shape the landscape of modern medicine. Dr. Roncatiā€™s leadership, influence, and groundbreaking discoveries solidify his status as one of the leading medical researchers of our time. He is undoubtedly a deserving candidate for the Best Researcher Award.

Publications Top Notedāœ

1. Title: Adjuvant Metronomic Chemotherapy After Surgery in pT1-T2 N0 M0 HER2-Positive and ER/PR-Positive Breast Cancer Plus Targeted Therapy, Anti-Hormonal Therapy, and Radiotherapy, with or Without Immunotherapy: A New Operational Proposal

  • Author: Roncati, Luca
    Year: Not specified
    Citations: 0

2. Title: Ozoneā€“Oxygen Therapy to Prevent HPV-Related Cancers of the Lower Gynecological Tract in Infected Patients: The Rationale for Further Developments

  • Author: Roncati, Luca
    Journal: Cancers
    Year: 2025
    Citations: 0

3. Title: COVID-19 and upper limb compression neuropathies: a review

  • Authors: Marra, Caterina; de Maria, Federico; Boccaletti, Martina; Roncati, Luca; Adani, Roberto
    Year: Not specified
    Citations: 0

4. Title: Ultramicronized Palmitoylethanolamide and Luteolin: Drug Candidates in Post-COVID-19 Critical Illness Neuropathy and Positioning-Related Peripheral Nerve Injury of the Upper Extremity

  • Authors: Roncati, Luca; Marra, Caterina; Gravina, Davide; Della Rosa, Norman; Adani, Roberto
    Journal: Journal of Hand and Microsurgery
    Year: 2024
    Citations: 3

 

5. Title: A Real-World Nationwide Study on COVID-19 Trend in Italy during the Autumnā€“Winter Season of 2020 and 2021 Integrated with a Retrospective Analysis of the Mortality Burden per Year

  • Authors: Manenti, Antonio; Roncati, Luca; Sorrentino, Lorena; Gelmini, Roberta; Coppi, Francesca
    Journal: Vascular
    Year: 2024
    Citations: 0

6. Title: Thoracic aortic pseudoaneurysm: Inside its pathophysiology

  • Authors: Manenti, Antonio; Roncati, Luca; Sorrentino, Lorena; Gelmini, Roberta; Coppi, Francesca
    Journal: Vascular
    Year: 2024
    Citations: 0

7. Title: Editorial: Endocrine disruptors and diseases of brain and mind: past and prelude

  • Authors: Johri, Ashu; Roncati, Luca; Lizcano, Fernando
    Year: Not specified
    Citations: 1

8. Title: Reply to: Letter on the Recent Paper ā€œVascular ā€˜Long COVIDā€™: A New Vessel Disease?ā€

  • Authors: Johri, Ashu; Roncati, Luca; Lizcano, Fernando
    Year: Not specified
    Citations: 1

9. Title: Vascular ā€œLong COVIDā€: A New Vessel Disease?

  • Authors: Zanini, Giada; Selleri, Valentina; Roncati, Luca; Pinti, Marcello; Mattioli, Anna Vittoria
    Year: Not specified
    Citations: 37

10. Title: Trends in the COVID-19 Pandemic in Italy during the Summers of 2020, 2021 and 2022: A Real-World Nationwide Study

  • Authors: Roncati, Luca; Bartolacelli, Giulia; Galeazzi, Carlo; Caramaschi, Stefania
    Journal: Pathogens
    Year: 2023
    Citations: 3